TRITONPOINT WEALTH, LLC

Position in ABBV — AbbVie Inc.

CIK 2008171 CHEVY CHASE, MD

Position in ABBV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,642,974

+$168,808 QoQ

Shares Held

10,503

-7.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#1,742

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TRITONPOINT WEALTH, LLC holds $34,735,241 across 9 Drug Manufacturers - General names. ABBV ranks #4 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	67,646	$17,180,054
2	MRK	Merck & Co., Inc.	58,703	$7,543,335
3	LLY	ELI LILLY & Co	3,728	$4,471,475
4	ABBV	AbbVie Inc. This page	10,503	$2,642,974
5	BMY	Bristol Myers Squibb Co	21,570	$1,242,863
6	PFE	Pfizer Inc	28,412	$684,160
7	AMGN	Amgen Inc	1,266	$458,443
8	GILD	Gilead Sciences, Inc.	2,045	$258,365

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,642,974	10,503	-7.7%	Shares	Sole	2026-08-11
2026-03-31	$2,474,166	11,376	-6.0%	Shares	Sole	2026-04-21
2025-12-31	$2,764,272	12,098	-4.3%	Shares	Sole	2026-01-20
2025-09-30	$2,925,739	12,636	+1.8%	Shares	Sole	2025-10-15
2025-06-30	$2,304,657	12,416	+1.7%	Shares	Sole	2025-07-17
2025-03-31	$2,556,772	12,203	+7.3%	Shares	Sole	2025-04-16
2024-12-31	$2,020,982	11,373	+5.9%	Shares	Sole	2025-01-24
2024-09-30	$2,120,935	10,740	+6.9%	Shares	Sole	2024-10-28
2024-06-30	$1,722,575	10,043	-15.1%	Shares	Sole	2024-08-12
2024-03-31	$2,154,243	11,830	-8.7%	Shares	Sole	2024-04-25
2023-12-31	$2,009,031	12,964	—	Shares	Sole	2024-01-24
No filing history on record for this holder in this stock.